Package 0186-0777-60

{"route": ["ORAL"], "spl_id": "c664bf3d-f861-4588-afbf-c3c52f1ae430", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1116639", "1666332", "1666334"], "spl_set_id": ["f7b3f443-e83d-4bf2-0e96-023448fed9a8"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "8 TABLET in 1 BOTTLE (0186-0777-08)", "package_ndc": "0186-0777-08", "marketing_end_date": "20260430", "marketing_start_date": "20110805"}, {"sample": false, "description": "10 BLISTER PACK in 1 BOX, UNIT-DOSE (0186-0777-39)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "0186-0777-39", "marketing_start_date": "20110805"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (0186-0777-60)", "package_ndc": "0186-0777-60", "marketing_start_date": "20110805"}], "brand_name": "BRILINTA", "product_id": "0186-0777_c664bf3d-f861-4588-afbf-c3c52f1ae430", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "0186-0777", "generic_name": "Ticagrelor", "labeler_name": "AstraZeneca Pharmaceuticals LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BRILINTA", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "NDA022433", "marketing_category": "NDA", "marketing_start_date": "20110805", "listing_expiration_date": "20261231"}